Dexin Services Group Limited: Poll Results of Extraordinary General Meeting on Capital Increase Agreement
Dexin Services Group Limited (Stock Code: 2215), a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange, has announced the poll results of its Extraordinary General Meeting (EGM) held on 11 March 2026. The meeting was convened to consider and approve transactions under the Capital Increase Agreement, a matter of potential significance to shareholders and the company’s future direction.
Key Highlights from the EGM
- Resolution Passed Unanimously: The sole ordinary resolution, which sought shareholder approval for the transactions under the Capital Increase Agreement, was overwhelmingly approved. The vote was almost unanimous, with 646,447,390 shares (100%) cast in favour of the resolution and just 3 shares (0.000000%) against.
- High Shareholder Participation: As of the EGM date, there were 917,881,000 shares in issue. After accounting for required abstentions, 903,615,259 shares were eligible to vote on the resolution.
- Abstention by Interested Director: Mr. Tang Junjie, an executive Director and beneficial owner of approximately 1.55% of the company’s shares, abstained from voting. Mr. Tang is also a limited partner of Deqing Kaisibo with a significant partnership interest (46.91%) and was deemed or perceived to have a material interest in the Capital Increase Agreement. No other shareholders were required to abstain.
- Independent Scrutiny: The poll was overseen by Computershare Hong Kong Investor Services Limited, ensuring transparency and accuracy of the voting process.
- Full Board Attendance: All board members, including both executive and independent non-executive directors, attended the meeting, reflecting the importance of the resolution and the company’s commitment to corporate governance.
Details for Shareholders
- Nature of the Resolution: The resolution pertained to the approval of transactions under the Capital Increase Agreement. While the full text of the resolution was referenced in the Notice and Circular, the announcement confirms that it relates to the company’s intention to raise additional capital through the agreement.
- Implications for Shareholders: The approval of the Capital Increase Agreement may pave the way for an infusion of new capital into the company, which could be used for strategic investments, expansion, or strengthening the balance sheet. This development could have a material impact on the company’s financial position and, potentially, its share price, depending on the terms and execution of the agreement.
- Corporate Governance: The abstention by an interested director, Mr. Tang Junjie, reinforces the company’s adherence to best practices in managing conflicts of interest and ensuring that only independent shareholders determine the outcome of related-party transactions.
Potential Price-Sensitive Information
- Capital Increase is Price Sensitive: The successful passing of a resolution to approve a capital increase is typically viewed as price-sensitive information. The market may react positively to the prospect of enhanced capital resources, especially if the funds are earmarked for growth or debt reduction. Conversely, if the capital increase results in significant dilution of existing shareholdings, this could also affect the share price.
- No Stated Opposition or Abstention: No shareholders, other than Mr. Tang Junjie (due to his material interest), had indicated any intention to vote against or abstain from voting on the resolution, suggesting broad support for the proposal.
Additional Important Details
- Directors Present: The Board of Dexin Services Group Limited currently comprises Mr. Hu Yiping (Chairman), Mr. Tang Junjie, and Ms. Zheng Peng as executive Directors; and Dr. Wong Wing Kuen Albert, Mr. Rui Meng, and Mr. Yang Xi as independent non-executive Directors.
- Regulatory Compliance: The company confirmed compliance with the Hong Kong Listing Rules, particularly the requirements around voting and abstention on connected transactions.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should carefully review all relevant disclosures and consider their own circumstances before making investment decisions. The information is based on company announcements as of 11 March 2026 and may be subject to further updates and clarifications.
View DEXIN SER GROUP Historical chart here
